Skip to content

The effects of aspiration biopsy of suspicious lung cancer originated-cervical lymph node metastasis guided by image fusion of real-time ultrasound and PET/CT

The effects of aspiration biopsy of suspicious lung cancer originated-cervical lymph node metastasis guided by image fusion of real-time ultrasound and PET/CT

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082245
Enrollment
Unknown
Registered
2024-03-25
Start date
2024-03-25
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

PET/CT and ultrasound fusion imaging group:Image-guided needle biopsy using PET/CT and ultrasound fusion imaging
Ultrasound imaging group:Guided needle biopsy using traditional real-time ultrasound images

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: From March 2024 to February 2026, patients with suspected supraclavicular lymph node metastasis in the Lung Cancer Center of, West China Hospital of Sichuan University, who are expected to undergo ultrasound-guided needle biopsy of cervical lymph nodes with abnormal structure or morphology (including suspicious metastatic lymph nodes in other parts such as the armpit if necessary).

Exclusion criteria

Exclusion criteria: (1) Patients with obvious enlarged lymph nodes can be palpated on physical examination; (2) Patients with a single lymph node with a short diameter >1.5cm; (3) Patients with contraindications to needle biopsy (e.g., lack of safe percutaneous puncture pathway, coagulation dysfunction, etc.); (4) Patients with systemic or local acute inflammation that need to be treated; (5) Refusal to participate in the study patients.

Design outcomes

Primary

MeasureTime frame
Needle pathological biopsy results and clinical diagnosis three months after needle biopsy;

Secondary

MeasureTime frame
Time required for needle biopsy procedure (minutes);Procedure-related adverse effects during or after needle biopsy;

Countries

P.R. China

Contacts

Public ContactXi Zheng

West China Hospital, Sichuan University

zheng.xi@foxmail.com+86 189 8060 3551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026